
Project ALS Introduces Prosetin
What’s Prosetin? If you’ve been following Project ALS, you have probably heard us mention PHB, our working name for The Core’s first drug candidate-in-development. Now,

What’s Prosetin? If you’ve been following Project ALS, you have probably heard us mention PHB, our working name for The Core’s first drug candidate-in-development. Now,

Since 2014, Project ALS has run an online campaign, the Don’t-Talk-a-Thon, during the month of May, in honor of ALS Awareness Month. For one day

Project ALS has partnered with Wine & Design, the awesome paint and sip franchise. During ALS Awareness month in May 2017 and 2018, Wine &

Project ALS is thrilled to welcome Dr. Ai Yamamoto to the Research Advisory Board and recognizes her leadership as she is joining our decision-making body.

Join us on Tuesday, June 4th at 7:10 PM as the New York Mets take on the San Francisco Giants When Project ALS was founded by the

To create a personal fundraising page: Why create a personal fundraising page? This option allows you to create your own, unique fundraising page that can

Columbia University and Project ALS today announced the Project ALS Therapeutics Core at Columbia (THE CORE), a 3-year, $6.3M initiative toward the first meaningful therapies

Q&A with Project ALS Researcher Dr. Sebastian Thams, Karolinska Institute, on His Recent Discovery, Published in Molecular Therapy Can you describe your discovery that was

Joesph Klim, PhD, a Kirchhoff Family Fellow at the Lab of Kevin Eggan, PhD at Harvard University has discovered that restoring expression of the gene

Project ALS and Columbia University’s Eleanor and Lou Gehrig ALS Center have opened the ALS Families Project to study relatives of ALS patients who carry

Last year, we announced the formation of a six-lab collaboration at the direction of Project ALS to focus on the cell process known as autophagy,

In the medical research world, a “post-doctoral fellow” is the official title for a gifted, young scientist who works 25 hours a day in a